decisionhealth Newsletters, Part B News - 2018 Issue 7 (July)
Use JW modifier for skin substitute biologics from a single package
Subscribe or sign in to view the full article.
Article Overview
This article covers Medicare-related billing guidance for skin substitute products, including when a discarded amount from a single-use package should be reported with the JW modifier. It is relevant to medical coders, billers, and practice staff who handle wound care and skin substitute claims, and it discusses related CPT application codes, HCPCS product codes, documentation expectations, and payer guidance sources.
Why This Topic Matters
Skin substitute claims can be denied or processed incorrectly if product wastage and application details are not documented and reported appropriately. The article helps coding and billing staff understand the general areas of guidance involved so they can review the full premium content for operational details.
What You Will Learn
- How the article frames Medicare billing guidance for skin substitute products
- What types of skin substitute-related coding references are discussed
- Why documentation of product use and wastage matters for claims processing
- Which organizations and reference materials are cited as sources of guidance
Who Should Read This
- Medical coders
- Medical billers
- Revenue cycle staff
- Wound care practice staff
- Compliance staff
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com